Novel Coronavirus (SARS-CoV-2/COVID-19)
Sens. Mark Warner, D-Va., and Tim Scott, R-S.C., introduced the Getting Early Treatment and Comprehensive Assessments Reduces Emergencies (GET CARE) Act, which would encourage patients to continue seeking preventive care during the COVID-19 pandemic, including disseminating scientific and evidence-…
Rural hospitals, already facing enormous challenges, quickly adapted when COVID-19 reached their communities. In this blog, John Supplitt, senior director of AHA Rural Health Services, points to the many examples of rural teams using innovative measures to improve quality of patient care during the…
A divided Congress. A lapsed deadline to pass important legislation. And uncertainty about how the situation will end.
Virginia launched the first COVID-19 contact tracing app based on the exposure notifications system application programming interface developed by Apple and Google.
The National Institutes of Health announced the Medical Imaging and Data Resource Center, a public-private initiative that will create medical imaging tools to detect and personalize therapies for COVID-19 patients.
The National Institute of Allergy and Infectious Diseases has launched a clinical trial to evaluate a potential COVID-19 treatment regimen for hospitalized patients that combines remdesivir with interferon beta-1a, a medication approved to treat multiple sclerosis that laboratory studies suggest…
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinical partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,000 health care leaders who belong to our professional membership groups…
Join AHA’s Board Chair Dr. Mindy Estes for Leadership Rounds as she discusses key issues with Dr. Harsh K. Trivedi, President and CEO, Sheppard Pratt. Watch the live stream at 3:30 p.m. to 3:45 p.m. ET/2:30 p.m. to 2:45 p.m. CT/12:30 a.m. to 12:45 a.m. PT, and come back to listen to the podcast and…
More than one in four individuals in a recent national survey reported they would wait four months or longer to seek previously skipped medical care due to fear of COVID-19.
Health care facilities or providers facing inadequate supplies of certain drugs needed to treat patients with COVID-19 should not use the products more than four hours beyond the labeled “in-use time” for refrigerated storage or two hours beyond the labeled “in-use time” for room temperature…